Prothena (PRTA) Investor Presentation - Slideshow

Prothena Corporate Overview May 2021 Forward-Looking Statements 2 This overview contains forward-looking statements. These statements relate to, among other things: the sufficiency of our cash position to fund advancement of a broad pipeline; the continued advancement of our discovery, preclinical and clinical pipeline and expected milestones in 2021 and beyond; our goal of building a protein dysregulation platform; the treatment potential, designs, and proposed mechanisms of action of birtamimab, prasinezu ...